Hepatitis E and pregnancy: current state

Reviews in Medical Virology

Volumn 27, Issue 3, 2017, Pages

  Pérez Gracia, María Teresa ^a   Suay García, Beatriz ^a   Mateos Lindemann, María Luisa ^b  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

hepatitis E; hepatitis E virus; pathogenesis; pregnancy; treatment

Indexed keywords

HEPATITIS VACCINE; RIBAVIRIN;

CD4 CD8 RATIO; CLINICAL FEATURE; DISEASE TRANSMISSION; ENZYME IMMUNOASSAY; FETUS DEATH; HEPATITIS E; HUMAN; IMMUNE RESPONSE; MATERNAL MORBIDITY; MATERNAL MORTALITY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREGNANCY; PROPHYLAXIS; REVIEW; TRANSFUSION; VACCINATION; VERTICAL TRANSMISSION; VIRAL CLEARANCE; VIRUS CAPSID; VIRUS HEPATITIS; ZOONOTIC TRANSMISSION;

EID: 85018380383     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1929     Document Type: Review

References (87)

1. WHO. Hepatitis E vaccine: WHO position paper. Wkly Epidemiol Rec. 2015;18:185-200.
2. Pérez-Gracia MT, Suay-García B, García M, Mateos-Lindemann ML. Hepatitis E: Latest developments in knowledge. Future Microbiol. 2016;11:789-808.
3. Pérez-Gracia MT, Mateos Lindemann ML, Montalvo Villalba MC. Hepatitis E: Current status. Rev Med Virol. 2013;23:384-398. doi: 10.1002/rmv
4. Lee GH, Tan BH, Chi-Yuan E, et al. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology. 2016;150:355-357 e353.
5. Pérez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: An emerging disease. Infect Genet Evol. 2014;22:40-59. doi: 10.1016/j.meegid.2014.01.002
6. Woo PC, Lau SK, Teng JL, Cao KY, Wernery U, Schountz T, Chiu TH, Tsang AK, Wong PC, Wong EY, YuenKY. New Hepatitis E Virus genotype in Bactrian camels, Xinjiang, China, 2013. Emer Infect Dis 2016; 22: 2219-2221. doi: 10.3201/eid2212.160979
7. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: Understanding the pathogenesis. Liver Int. 2008;28:1190-1199. doi: 10.1111/j.1478-3231.2008.01840.x
8. Hussaini SH, Skidmore SJ, Richardson P, Sherratt LM, Cooper BT, O'Grady JG. Severe hepatitis E infection during pregnancy. J Viral Hepat. 1997;4:51-54.
9. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55:988-997.
10. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007a;147:28-33.
11. Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome. Hepatology. 1996;23:1448-1455.
12. Aziz AB, Hamid S, Iqbal S, Islam W, Karim SA. Prevalence and severity of viral hepatitis in Pakistani pregnant women: A five year hospital based study. J Pak Med Assoc. 1997;47:198-201.
13. Balayan MS, Andjapardize AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via faecal-oral route. Intervirology. 1983;20:23-31.
14. Shrestha S et al. An epidemic of hepatitis E in Nepal: Clinical and epidemiological study. J Inst Med. 1990;12:195-204.
15. Dilawari JB, Singh K, Chawla YK, et al. Hepatitis E virus: Epidemiological, clinical, and serological studies of north Indian epidemic. Indian J Gastroenterol. 1994;13:44-48.
16. Khuroo MS. Hepatitis E: The enterically transmitted non-A, non-B hepatitis. Indian J Gastroenterol. 1991;10:96-100.
17. Bile K, Isse A, Mohamud O, et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg. 1994;51:466-474.
18. Lubis I. Outbreak of hepatitis E in West Kalimantan. Cermin Dunia Kedokteran. 1994;95:43-46.
19. Mast E, Polish LB, Favorov MO, et al. Hepatitis E among refugees in Kenya: minimal apparent person-to-person transmission, evidence for age-dependent disease expression, and new serological assays. In: Kishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer-Verlag; 1994:375-378.
20. Naik SR, Aggarwal R, Salunke PN, et al. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ. 1992;70:597-604.
21. Coursaget P, Buisson Y, Enogat N, et al. Outbreak of enterically-transmitted hepatitis due to hepatitis A and hepatitis E viruses. J Hepatol. 1998;28:745-750.
22. Rab MA, Bile MK, Mubarik MM, et al. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: A common source out-break traced to the malfunction of a modern water treatment plant. Am J Trop Med Hyg. 1997;57:151-157.
23. Goumba AI, Konamna X, Komas NP. Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic. BMC Infect Dis. 2011;11:93.
24. Boccia D, Guthmann JP, Klovstad H, et al. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis. 2006;42:1679-1684.
25. Teshale EH, Howard CM, Grytdal SP, et al. Hepatitis E epidemic, Uganda. Emerg Infect Dis. 2010;16:126-129.
26. International Centre for Diarrhoeal Disease Research, Bangladesh. Outbreak of hepatitis E in a low income urban community in Bangladesh. Health Sciences Bulletin. 2009;7:14-20.
27. International Centre for Diarrhoeal Disease Research, Bangladesh. Hepatitis E outbreak in Rajshahi City Corporation. Health Science Bulletin. 2010;8:12-18.
28. Rayis DA, Jumaa AM, Gasim GI, Karsany MS, Adam I. An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan. Pathog Glob Health. 2013;107:66-68.
29. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet. 2012;379:2477-2488.
30. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27:116-138.
31. Lindemann ML, Gabilondo G, Romero B, de la Maza OM, Pérez-Gracia MT. Low prevalence of hepatitis E infection among pregnant women in Madrid, Spain. J Med Virol. 2010;82:1666-1668. doi: 10.1002/jmv.21840
32. Anty R, Ollier L, Péron JM, et al. First case report of an acute genotype 3 hepatitis E infected pregnant woman living in south-eastern France. J Clin Virol. 2012;54:76-78.
33. Tabatabai J, Wenzel JJ, Soboletzki M, Flux C, Navid MH, Schnitzler P. First case report of an acute hepatitis E subgenotype 3c infection during pregnancy in Germany. J Clin Virol. 2014;61:170-172.
34. Renou C, Gobert V, Locher C, et al. Prospective study of hepatitis E virus infection among pregnant women in France. Virol J. 2014;11:68.
35. Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Tomas L. Seroprevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol. 2001;100:9-15.
36. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet. 1995;345:1025-1026.
37. Krain LJ, Kenrad A, Nelson E, Labrique AB. Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection. Am J Trop Med Hyg. 2014;90:365-370.
38. Lanini S, Garbuglia AR, Lapa D, et al. Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy. BMJ Open. 2015;5(7):e007110.
39. Lachish T, Erez O, Daudi N, Shouvaal D, Schwarts E. Acute hepatitis E virus in pregnant women in Israel and in other industrialized countries. J Clin Virol. 2015;73:20-24.
40. Sayed I, Vercouter AS, Abdelwahab S, Vercautresn K, Meuleman P. Is hepatitis E virus an emerging problem in industrialized countries? Hepatology. 2015;62:1883-1892.
41. Khuroo MS, Kamil S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat. 2003;10:61-69.
42. Kaskheli MN, Baloch S, Sheeba A, Baloch S. Acute hepatitis E viral infection in pregnancy and maternal morbidity. J Coll Physicians Surg Pak. 2015;24:734-737.
43. Chaundhry S, Verma N, Koren D. Hepatitis E infection during pregnancy. Can Fam Physician. 2015;61:607-608.
44. Agravel V, Goel A, Rawat A, Nalk S, Aggarwal R. Histological and immunohistochemical features in fatal acute fulminant hepatitis E. Indian J Pathol Microbiol. 2012;55:22-27.
45. Pal R, Aggarwal R, Naik SR, Das V, Das S, Naik S. Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol. 2005;20:1094-1101. doi: 10.1111/j.1440-1746.2005.03875.x
46. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007b;147:28-33.
47. Prusty BK, Hedau S, Singh A, Kar P, Das BC. Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol Med. 2007;13:518-526. doi: 10.2119/2007-00055 Prusty
48. Jilani N, Das BC, Husain SA, et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol. 2007;22:676-682. doi: 10.1111/j.1440-1746.2007.04913.x
49. Prabhu SB, Gupta P, Durgapal H, et al. Study of cellular immune response against hepatitis E virus (HEV). J Viral Hepat. 2011;18:587-594. doi: 10.1111/j.1365-2893.2010.01338.x
50. Bose PD, Das BC, Kumar A, Gondal R, Kumar D, Kar P. High viral load and deregulation of the progesterone receptor signaling pathway: Association with hepatitis E-related poor pregnancy outcome. J Hepatol. 2011;54:1107-1113. doi: 10.1016/j.jhep.2010.08.037
51. Salam GD, Kumar A, Kar P, Aggarwal S, Husain A, Sharma S. Serum tumor necrosis factor-alpha level in hepatitis E virus-related acute viral hepatitis and fulminant hepatic failure in pregnant women. Hepatol Res. 2013;43:826-835. doi: 10.1111/hepr.12028
52. Arya RP, Arankalle VA. Toll like receptors in self-recovering hepatitis E patients with or without pregnancy. Hum Immunol. 2014;75:1147-1154. doi: 10.1016/j.humimm.2014.10.011
53. Ramdasi AY, Arya RP, Arankalle VA. Effect of pregnancy on anti-HEV antibody titres, plasma cytokines and the corresponding gene expression levels in the PBMCs of patients presenting with self-recovering clinical and subclinical hepatitis E. PLoS One. 2014;9:e103257. doi: 10.1371/journal.pone.0103257
54. Kumar A, Devi SG, Kar P, et al. Association of cytokines in hepatitis E with pregnancy outcome. Cytokine. 2014;65:95-104.
55. Sehgal R, Patra S, David P, et al. Impaired monocyte-macrophage functions and defective toll-like receptor signaling in hepatitis E virus-infected pregnant women with acute liver failure. Hepatology. 2015;62:1683-1696. doi: 10.1002/hep.28143
56. Bhatnagar G, Sharma S, Kumar A, Prasad S, Agarwal S, Kar P. Reduced glutathione in hepatitis E infection and pregnancy outcome. J Obstet Gynaecol Res. 2016;42:789-795. doi: 10.1111/jog.12986
57. Kmush BL, Labrique A, Li W, et al. The Association of Cytokines and Micronutrients with hepatitis E virus infection during pregnancy and the postpartum period in rural Bangladesh. Am J Trop Med Hyg. 2016;94:203-211. doi: 10.4269/ajtmh.15-0238
58. Kar P, Jilani N, Husain SA, et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am J Gastroenterol. 2008;103:2495-2501. doi: 10.1111/j.1572-0241.2008.02032.x
59. Meeusen EN, Bischof RJ, Lee CS. Comparative T-cell responses during pregnancy in large animals and humans. Am J Reprod Immunol. 2001;46:169-179.
60. Labrique AB, Klein S, Kmush B, et al. Immunologic dysregulation and micronutrient deficiencies associated with risk of intrapartum hepatitis E infections in pregnant Bangladeshi women. FASEB J. 2012;26:127.4.
61. Jiang T, Christian P, Khatry SK, Wu L, West KP. Micronutrient deficiencies in early pregnancy are common, concurrent, and vary by season among rural Nepali pregnant women. J Nutr. 2005;135:1106-1112.
62. Scholl PF, Cole RN, Ruczinski I, et al. Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal. Placenta. 2012;33:424-432. doi: 10.1016/j.placenta.2012.02.009
63. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128. doi: 10.1016/S0140-6736(12)61728-0
64. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: A systematic review. Lancet. 2006;367:1066-1074. doi: 10.1016/S0140-6736(06)68397-9
65. Puri M, Patra S, Singh P, et al. Factors influencing occurrence of postpartum haemorrhage in pregnant women with hepatitis E infection and deranged coagulation profile. Obstet Med. 2011;4:108-112. doi: 10.1258/om.2011.110031
66. Geng Y, Yang J, Huang W, et al. Virus host protein interaction network analysis reveals that the HEV ORF3 protein may interrupt the blood coagulation process. PLoS One. 2013;8:e56320. doi: 10.1371/journal.pone.0056320
67. Ratra R, Kar-Roy A, Lal SK. ORF3 protein of hepatitis E virus interacts with the Bbeta chain of fibrinogen resulting in decreased fibrinogen secretion from HuH-7 cells. J Gen Virol. 2009;90:1359-1370.
68. Poliakova AM, Novozhenina EB, Danil'iants IL. The hemostatic system of patients with a severe course of viral hepatitis E. Ter Arkh. 1994;66:19-21.
69. Labrique AB, Sikder SS, Krain LJ, et al. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis. 2012;18:1401-1404. doi: 10.3201/eid1809.120241
70. Gurley ES, Halder AK, Streatfield PK, et al. Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: Possible role of hepatitis E infection. Am J Public Health. 2012;102:2248-2254. doi: 10.2105/AJPH.2012.300749
71. Arends JE, Gisetti V, Irving W, et al. Hepatitis E: An emerging infection in high income countries. J Clin Virol. 2014;59:81-88.
72. Baylis SA, Hanschmann KM, Blúmel J, Nubling CM. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: An initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol. 2011;49:1234-1239.
73. https://www.cobas68008800.com/wp-content/uploads/2015/poster_pdfs/Highly_Sensitive_and_Reproducible_Assay_for_Hepatitis_E_Blood_Screening_on_the_Cobas_6800_and_8800_Systems.pdf
74. Aggarwal R, Goel A. Advances in hepatitis E-I: Virology, pathogenesis and diagnosis. Expert Rev Gastroenterol Hepatol. 2016;10:1053-1063. doi: 10.1080/17474124.2016.1185362
75. Dawson GJ, Mushahwar IK, Chau KH, Gitnick GL. Detection of long-lasting antibody to hepatitis E virus in a US traveller to Pakistan. Lancet. 1992;340:426-427.
76. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV seroprevalence data in developed countries. J Med Virol. 2010;82:799-805.
77. Sakata H, Matsubayashi K, Takeda H, et al. A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase. Transfusion. 2008;48:2568-2576.
78. Norder H, Karlsson M, Mellgren A, et al. Diagnostic performance of five assays for anti-hepatitis E virus IgG and IgM in a large cohort study. J Clin Microbiol. 2016;54:549-555.
79. Herremans M, Bakker J, Duizer E, Vennema H, Koopmans MO. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol. 2007;14:562-568.
80. Legrand-Abravanel F, Thevenet I, Mansuy JM, et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol. 2009;16:772-774.
81. Chionne P, Madonna E, Pisani G, et al. Evaluation of rapid tests for diagnosis of acute hepatitis E. J Clin Virol. 2016;78:4-8.
82. Scobie L, Dalton HR. Hepatitis E: Source and route of infection, clinical manifestations and new developments. J Viral Hepat. 2013;20:1-11.
83. Rac MW, Sheffield JS. Prevention and Management of Viral Hepatitis in pregnancy. Obstet Gynecol Clin North Am. 2014;41:573-592.
84. Committee to Advise on Tropical Medicine and Travel (CATMAT). An advisory committee statement (ACS). Statement to travellers' diarrhea. Can Commun Dis Rep. 2001;27:1-12.
85. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A large-scale, randomized, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376:895-902.
86. Li SW, Zhao Q, Wu T, Chen S, Zhang J, Xia NS. The development of a recombinant hepatitis E vaccine HEV 239. Hum Vaccin Immunother. 2015;11:908-914.
87. Josh SS, Arankalle VA. Enhanced humoral response in pregnant mice immunized with liposome encapsulated recombinant neutralizing epitope protein of hepatitis E virus. Virol J. 2015;12:70.